A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors

Publications

Download the full research reports and methodologies from the Foundation's three research programmes, as well as studies, articles and briefing papers on how pharmaceutical companies address specific access-to-medicine priorities.

All Access to Medicine Index Access to Vaccines Index AMR Benchmark Thematic studies Articles Viewpoints

published on 17 Mar 2016

Fighting the trade in falsified medical products: building a consensus on the role for the private sector

In their article, Laurien Rook, Researcher, and Danny Edwards, Research Programme Manager, at the Access to Medicine Foundation, highlight the ongoing...

Learn more

published on 29 Feb 2016

Pharmaceutical companies donating medicines in crisis situations

In the article, Catherine Gray and Suvi Karuranga, Researchers at the Access to Medicine Foundation, discuss the role of pharmaceutical companies in c...

Learn more

published on 19 Feb 2016

Stanford Social Innovation Review: Access by Prescription

In the article, Jayasree K. Iyer, Executive Director at the Access to Medicine Foundation, describes the corporate strategies that large pharmaceutica...

Learn more

published on 24 Nov 2015

Access to hepatitis C medicine

The Bulletin of the World Health Organization has published the latest study from the Access to Medicine Foundation: on how the world’s largest pharma...

Learn more

published on 20 Oct 2015

The R&D agenda and how it addresses access to vaccines

In this guest post, Dr. Jayasree K. Iyer, Chief Scientific Officer at the Access to Medicine Foundation, writes about the findings from their new...

Learn more

published on 23 Sep 2015

SDG SERIES: The Access to Medicine Index and Accountability of Pharmaceutical Companies

Damiano de Felice and Danny Edwards write about the Access to Medicine Index and Accountability of Pharmaceutical Companies as part of the SDG series....

Learn more

published on 22 Jul 2015

Are pharma giants living up to big promises on development?

In the article, Damiano de Felice and Jayasree K. Iyer write about how pharmaceutical companies are taking action to improve maternal health, and make...

Learn more

published on 19 Apr 2015

Medicin. Novo sikrer ulandenes adgang

Danish newspaper Politiken publishes a piece by Jayasree K. Iyer and Damiano de Felice. They give an overview of how Novo Nordisk performs in the 2014...

Learn more

published on 15 Mar 2015

Big Pharma and Social Responsibility — The Access to Medicine Index

The article sets out the methods of the Access to Medicine Index, touching upon the 2012 Index’ key findings and trends. Moreover, Professor Hogerzeil...

Learn more

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |